1. Home
  2. BKSY vs TBPH Comparison

BKSY vs TBPH Comparison

Compare BKSY & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$34.05

Market Cap

726.7M

Sector

Technology

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.36

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
TBPH
Founded
2013
2013
Country
United States
United States
Employees
340
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
726.7M
824.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BKSY
TBPH
Price
$34.05
$16.36
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$28.50
$18.40
AVG Volume (30 Days)
2.0M
510.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
279.13
EPS
N/A
2.06
Revenue
N/A
$15,386,000.00
Revenue This Year
$26.22
$1.04
Revenue Next Year
$29.28
N/A
P/E Ratio
N/A
$8.03
Revenue Growth
N/A
N/A
52 Week Low
$6.44
$8.32
52 Week High
$36.34
$21.03

Technical Indicators

Market Signals
Indicator
BKSY
TBPH
Relative Strength Index (RSI) 65.92 56.03
Support Level $16.87 $13.41
Resistance Level N/A $19.04
Average True Range (ATR) 3.59 0.51
MACD 0.77 0.30
Stochastic Oscillator 84.13 74.59

Price Performance

Historical Comparison
BKSY
TBPH

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: